Year 2017 / Volume 109 / Number 4
Case Report
Liver metastasis from neuroendocrine carcinoma after the use of the new direct-action antivirals against hepatitis C virus in a patient with past history of hepatocellular carcinoma

308-312

DOI: 10.17235/reed.2017.4772/2016

María Caldas, Lourdes del Campo, Alwalid Freih-Fraih, Luisa García-Buey,

Abstract
The use of the new direct-action antivirals against hepatitis C virus provides very high viral eradication rates. However, various recently published articles recommend caution with their use after the appearance of some cases of de novo tumors (originated in hepatic and extra-hepatic locations) and a possible shorter time period of recurrence of hepatocellular carcinomas previously treated with surgery or loco-regional therapies. The sudden drop of the number of natural killer cells secondary to the use of these new medicines has been suggested as one of the possible mechanisms responsible for this process. However, due to the controversy concerning this subject and the absence of long-term follow-up studies in clinical practice, caution is needed before definitive conclusions are settled. We present the case report of a patient diagnosed of chronic liver disease secondary to hepatitis C virus infection and a past history of hepatocellular carcinoma in complete remission after radiofrequency ablation. He was treated with the new direct-action antivirals reaching sustained viral response. Six months later, the patient was diagnosed with liver metastasis from a small-cell neuroendocrine tumor of unknown primary site.
Share Button
New comment
Comments
No comments for this article
References
1. EASL Recommendations on Treatment of Hepatitis C 2016. J Hepatol (2016). http://dx.doi.org/10.1016/j. jhep.2016.09.001
2. Moon C, Jung KS, Kim do Y, et al. Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin. Dig Dis Sci. 2015; 60(2):573-81.
3. Van der Meer AJ, Veldt BJ, Feld JJ, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012; 308(24):2584-93.
4. ANRS collaborative study group on hepatocellular carcinoma (ANRS C02 HEPATHER, CO21 CirVir and CO23 CUPILT cohorts). Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts. J Hepatol. 2016; 65(4):734-40.
5. Reig M, Mariño Z, Perelló C, et al. Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: a note of caution. J Hepatol. 2016; 65(4):719-726.
6. Lee EC, Kim SH, Park H, et al. Survival Analysis after Liver Resection for Hepatocellular Carcinoma: A Consecutive Cohort of 1002 Patients. J Gastroenterol Hepatol. 2016. DOI 10.1111/jgh.13632.
7. Conti F, Buonfiglioli F, Scuteri A, et al. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J Hepatol. 2016; 65(4):727-33.
8. Serti E, Chepa-Lotrea X, Kim YJ, et al. Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function. Gastroenterology 2015; 149(1):190–200.
9. Tatsumi T, Takehara T. Impact of natural killer cells on chronic hepatitis C and hepatocellular carcinoma. Hepatol Res. 2016; 46(5):416-22.
10. Lin RJ, Moskovits T, Diefenbach CS, et al. Development of highly aggressive mantle cell lymphoma after sofosbuvir treatment of hepatitis C. Blood Cancer J. 2016; 6:e402. DOI 10.1038/bcj.2016.16.
Related articles

Original

Hepatitis C in homeless people: reaching a hard-to-reach population

DOI: 10.17235/reed.2021.7737/2020

Citation tools
Caldas M, del Campo L, Freih-Fraih A, García-Buey L. Liver metastasis from neuroendocrine carcinoma after the use of the new direct-action antivirals against hepatitis C virus in a patient with past history of hepatocellular carcinoma. 4772/2016


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 143 visits.
This article has been downloaded 143 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 04/12/2016

Accepted: 27/01/2017

Online First: 13/03/2017

Published: 31/03/2017

Article revision time: 48 days

Article Online First time: 99 days

Article editing time: 117 days


Share
This article has been rated by 1 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology